Abstract
Breast cancer screening is generally accepted as an effective means of reducing breast cancer mortality in post-menopausal women. In this analysis the impact of nationwide screening on clinical medicine and the effects for the women involved are quantified. Effect estimates are based on results from screening trials in Utrecht (DOM-project) and Nijmegen, and on bi-annual screening of women aged 50-70. The consequences for health care are based on generally accepted assessment and treatment policies. The number of assessment procedures for non-palpable lesions will increase by 12% per year in the build-up period, and will remain slightly higher. The total number of biopsies in a real population is expected to decrease. Screening will lead to a shift in primary treatment modalities, as 15% of mastectomies will be replaced by breast conserving therapy. The temporary increase in the demand for primary treatment in the first years will be followed by a decrease in the demand for treating women with advanced disease. Favourable effects outweigh the inevitable unfavourable effects, with high quality screening and an appropriate invitation system. Breast cancer screening can also be recommended after considering other consequences than mortality reduction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Koning, H., van Oortmarssen, G., van Ineveld, B. et al. Breast cancer screening: its impact on clinical medicine. Br J Cancer 61, 292–297 (1990). https://doi.org/10.1038/bjc.1990.55
Issue Date:
DOI: https://doi.org/10.1038/bjc.1990.55
This article is cited by
-
Short‐ and Long‐Term (10‐year) Results of an Organized, Population‐Based Breast Cancer Screening Program: Comparative, Observational Study from Hungary
World Journal of Surgery (2018)
-
Decreased rates of advanced breast cancer due to mammography screening in The Netherlands
British Journal of Cancer (2004)